Last week, the U.S. Food and Drug Administration (FDA) published a draft guidance on the use of data monitoring committees (DMCs) in clinical trials entitled “Use of Data Monitoring Committees in ...
The US Food and Drug Administration (FDA) recently issued draft guidance with recommendations to help clinical trial sponsors determine when a data monitoring committee (DMC) would be beneficial for ...
The US Food and Drug Administration (FDA) on Monday issued a new draft guidance advising certain product sponsors to establish data monitoring committees (DMCs) to ensure that safety signals are ...
Data monitoring practices in clinical trials encompass the systematic oversight of accumulating participant data to safeguard safety, integrity and scientific validity. Core to these practices are ...
Industry advises practical fixes for new FDA guidance on data monitoring committees Stakeholder comments on new US Food and Drug Administration (FDA) draft guidance for data monitoring committees ...
MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation (Humanetics) is pleased to announce the positive results from the independent Data Safety Monitoring Board (DSMB) review of its phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results